about
Mood disorders in Huntington's disease: from behavior to cellular and molecular mechanismsMaintenance of basal levels of autophagy in Huntington's disease mouse models displaying metabolic dysfunctionThe Allure of High-Risk Rewards in Huntington's disease.Risk-taking and pathological gambling behavior in Huntington's diseasePresentation and care of a family with Huntington disease in a resource-limited community.Clinimetric properties of the Tinetti Mobility Test, Four Square Step Test, Activities-specific Balance Confidence Scale, and spatiotemporal gait measures in individuals with Huntington's diseaseReduced expression of conditioned fear in the R6/2 mouse model of Huntington's disease is related to abnormal activity in prelimbic cortex.Cerebral correlates of psychotic syndromes in neurodegenerative diseasesDepression in the early stages of Huntington disease.Intracerebroventricular administration of lipopolysaccharide induces indoleamine-2,3-dioxygenase-dependent depression-like behaviors.Characterization of depression in prodromal Huntington disease in the neurobiological predictors of HD (PREDICT-HD) study.Impulsivity and apathy in Parkinson's disease.Dopamine imbalance in Huntington's disease: a mechanism for the lack of behavioral flexibility.Ekbom syndrome occurring with multi infarct dementia.Bipolar affective disorder in Huntington's disease: A neuropsychiatric perspective.Disease-modifying effects of ganglioside GM1 in Huntington's disease models.Gray Matter Volume of a Region in the Thalamic Pulvinar Is Specifically Associated with Novelty Seeking.Beneficial effects of Panax ginseng for the treatment and prevention of neurodegenerative diseases: past findings and future directions.
P2860
Q21131050-0D14C1C3-0577-4909-818A-838FD98E1D6CQ27341821-896C4E34-FBCE-4A4F-8087-B7315B4E93C2Q30277857-D29CF6D1-57DB-422B-AB35-F70951545502Q30439699-49F4A33F-E55A-47C0-A5B6-4D394D539DBBQ33556293-EFE46F86-C099-448A-ADC5-6D406EC8B38DQ34502749-509CADB1-A43B-4D90-A791-4309EE6224F1Q35042882-427F1BC4-D4A8-4336-A8EE-5B0289A0BBD0Q35194993-66AD0FC4-275F-491E-A9A3-B154A3520101Q36197669-29DD90B3-E00E-4128-83EB-BD02DD112E32Q37071182-5F93BFDB-9519-4A6D-A28A-131297072926Q37254698-CC59631D-5451-4550-A38F-C2D335BBA6ADQ37331607-DA6CD394-2999-4E90-A56E-4DDBEB37CA95Q38121068-640F30A0-E3E2-49E1-AE82-F1C5C33762F6Q40833146-6FDBB719-BCF8-4869-BD83-F4A6F5600626Q41840994-B0EB7848-418A-4CEC-BBFD-9AF3D2554FF1Q47154575-5358D936-8515-4B6F-84E8-992E530CF421Q53435002-6618BD22-FF86-4613-91F4-4DA44FE94E21Q55510296-BBC6A740-4907-43F6-B96B-DA50B03A850A
P2860
description
2007 nî lūn-bûn
@nan
2007 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2007 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
name
Neuropsychiatry of Huntington's disease.
@ast
Neuropsychiatry of Huntington's disease.
@en
type
label
Neuropsychiatry of Huntington's disease.
@ast
Neuropsychiatry of Huntington's disease.
@en
prefLabel
Neuropsychiatry of Huntington's disease.
@ast
Neuropsychiatry of Huntington's disease.
@en
P2860
P921
P1476
Neuropsychiatry of Huntington's disease.
@en
P2093
Adam Rosenblatt
P2860
P304
P5008
P577
2007-01-01T00:00:00Z